MedAvante Rater ReadinessTraining

By: Medavante  06-Dec-2011
Keywords: Value Proposition, Thought Leaders, Interviewing Skills

Research indicates that clinical interviewing skill is a key factor in enhancing signal detection and can greatly influence a trial’s success or failure. To provide the highest levels of rater training, MedAvante offers enriched Rater Readiness training, a superior approach that puts extraordinary emphasis on the rater's applied interviewing skills which is representative of real world trial conditions.

All rater training programs do not provide the same level of thoroughness and depth as MedAvante's Rater Readiness program:

  • MedAvante trainers spend 5.5-16 hours per rater in applied interviewing training vs 10 minutes in other commercial programs
  • Has trained raters throughout the world
  • Provides a unique combination of conceptual knowledge with intensive applied clinical skills training and testing
  • Is the only rater training program that has been empirically validated to effectively train in both concepts and clinical skills

MedAvante's Rater Readiness Training is also the first step to level set raters for CQC, quality control by Centralized Expert Trainers.

MedAvante's team of expert trainers is composed of research scientists and clinicians who are thought leaders in rater training and assessment. Each MedAvante senior scientist has engaged in funded research examining improved assessment methodologies, has authored psychiatric scales and/or has led efforts to update current scales.

Rater Readiness can help sponsors increase objectivity in their CNS clinical trials. The result can be greater certainty in maximizing the value proposition for CNS products and delivering effective therapies for treating debilitating CNS diseases.

Keywords: Interviewing Skills, Thought Leaders, Value Proposition

Contact Medavante

Email - none provided

Print this page

Other products and services from Medavante


MedAvante Products & Services

Sponsors of CNS clinical trials can select precisely the level of service needed to achieve their goals for signal detection, study power, and inter-rater reliability. Toward that end, MedAvante offers four levels of service, each based on our highly precise methodology for increasing objectivity in CNS studies. MedAvante is dedicated to bringing certainty to the mental-health evaluations and assessments performed during CNS clinical trials.


MedAvante: Solutions

By applying this methodology, MedAvante overcomes the major threat to achieving signal detection: Issues with the trial assessments’ validity and reliability caused by biases and interviewer variability. An entire cohort of study raters comprised of high quality interviewers can still result in poor reliability for the study as a whole, with an attendant negative effect on study power.


Remote Centralized Ratings

MedAvante’s Remote Centralized Ratings service addresses issues of baseline score inflation and expectancy bias by providing the services of expert, clinical raters working remotely from a central location. The result for sponsors is the highest level of certainty in maximizing the value proposition for their CNS products and delivering effective therapies for treating debilitating CNS diseases.


Continuous Quality Control Monitoring Service

Provides own score of interview scale: automated workflow program will not provide site's scores until MedAvante expert trainer enters their assessment scores. MedAvante expert trainers are calibrated to provide consistent feedback to all site raters to minimize rater variability. Site-based raters digitally record all their subject interviews through provided laptop. Calibrate the site raters to the central MedAvante expert trainer cohort.


MedAvante Patient Ascertainment

MedAvante can dramatically improve the accuracy of patient ascertainment by employing a bank of centralized calibrated expert raters to qualify patient enrollment during the initial screening process. By enrolling the right subject and accurately assessing their baseline symptom severity, MedAvante Patient Ascertainment service increases objectivity in CNS clinical trials.